A meta-analysis of topiramate's effects for individuals with alcohol use disorders

Alcoholism: Clinical and Experimental Research

Volumn 38, Issue 6, 2014, Pages 1481-1488

  Blodgett, Janet C ^a   Del Re, A C ^a   Maisel, Natalya C ^a   Finney, John W ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohol Use Disorders; Meta Analysis; Topiramate; Treatment

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; PLACEBO; TOPIRAMATE; AMINO ACID RECEPTOR BLOCKING AGENT; FRUCTOSE;

ALCOHOL ABSTINENCE; ALCOHOL WITHDRAWAL; ALCOHOLISM; DRINKING BEHAVIOR; DRUG EFFECT; HEAVY DRINKING; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY ANALYSIS; ANALOGS AND DERIVATIVES; EPIDEMIOLOGY; TREATMENT OUTCOME;

ALCOHOL DRINKING; ALCOHOLISM; EXCITATORY AMINO ACID ANTAGONISTS; FRUCTOSE; HUMANS; TREATMENT OUTCOME;

EID: 84901936461     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/acer.12411     Document Type: Review

References (41)

1. Anton RF, Moak DH, Latham PK (1996) The obsessive compulsive drinking scale: a new method of assessing outcome in alcoholism treatment studies. Arch Gen Psychiatry 53:225-231.
2. Arbaizar B, Dierssen-Sotos T, Gomez-Acebo I, Llorca J (2010) Topiramate in the treatment of alcohol dependence: a meta-analysis. Actas Esp Psiquiatr 38:8-12.
3. Arnone D (2005) Review of the use of topiramate for treatment of psychiatric disorders. Ann Gen Psychiatry 4:5-19.
4. Aubin H-J, Daeppen J-B (2013) Emerging pharmacotherapies for alcohol dependence: a systematic review focusing on reduction in consumption. Drug Alcohol Dep 133:15-29.
5. Baltieri DA, Daro FR, Ribeiro PL, de Andrade AG (2008) Comparing topiramate with naltrexone in the treatment of alcohol dependence. Addiction 103:2035-2044.
6. Borenstein M (2009) Effect sizes for continuous data, in The Handbook of Research Synthesis and Meta-analysis, 2nd ed (Cooper H, Hedges LV, Valentine JC eds), pp 221-235. Russell Sage Foundation, New York.
7. Borenstein M, Hedges LV (2009) Introduction to Meta-Analysis. John Wiley & Sons Inc, Hoboken, NJ.
8. Cohen J (1988) Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Lawrence Erlbaum, Hillsdale, NJ.
9. Cuijpers P, van Straten A, Bohlmeijer E, Hollon SD, Andersson G (2009) The effects of psychotherapy for adult depression are overestimated: a meta-analysis of study quality and effect size. Psychol Med 40:211-223.
10. Del Re AC (2013) RcmdrPlugin.MA: Graphical User Interface for Conducting Meta-Analysis in R [statistical software program]. R Package version 0.0-1.
11. Del Re AC, Gordon AJ, Lembke A, Harris AH (2013a) Prescription of topiramate to treat alcohol use disorders in the Veterans Health Administration. Addict Sci Clin Pract 8:12-20.
12. Del Re AC, Hoyt WT (2010) MAd: Meta-Analysis With Mean Differences [statistical software program]. R Package Version 0.8. Madison, WI.
13. Del Re AC, Maisel N, Blodgett J, Finney J (2013b) The declining efficacy of naltrexone pharmacotherapy for alcohol use disorders over time: a multivariate meta-analysis. Alcohol Clin Exp Res 37:1064-1068.
14. Duval S, Tweedie R (2000) Trim and Fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56:455-463.
15. Feinn R, Kranzler HR (2005) Does effect size in naltrexone trials for alcohol dependence differ for single-site vs. multi-center studies? Alcohol Clin Exp Res 29:983-988.
16. Finney JW (2008) Regression to the mean in substance use disorder treatment research. Addiction 103:42-52.
17. Flannery B, Volpicelli J, Pettinati H (1999) Psychometric properties of the Penn Alcohol Craving Scale. Alcohol Clin Exp Res 23:1289-1295.
18. Florez G, Garcia-Portilla P, Alvarez S, Saiz PA, Nogueiras L, Bobes J (2008) Using topiramate or naltrexone for the treatment of alcohol-dependent patients. Alcohol Clin Exp Res 32:1251-1259.
19. Florez G, Saiz PA, Garcia-Portilla P, Alvarez S, Nogueiras L, Bobes J (2011) Topiramate for the treatment of alcohol dependence: comparison with naltrexone. Eur Addict Res 17:29-36.
20. Gleser L, Olkin I (2009) Stochastically dependent effect sizes, in The Handbook of Research Synthesis and Meta-Analysis, 2nd ed (Cooper H, Hedges LV, Valentine JC eds), pp 357-376. Russell Sage Foundation, New York.
21. Good PI (2005) Permutation, Parametric, and Bootstrap Tests of Hypotheses. 3rd ed. Springer, New York.
22. Haddock CK, Rindskopf D, Shadish WR (1998) Using odds ratios as effect sizes for meta-analysis of dichotomous data: a primer on methods and issues. Psychol Methods 3:339-353.
23. Hedges LV, Olkin I (1985) Statistical Methods for Meta-Analysis. Academic Press, San Diego, CA.
24. Hedges LV, Tipton E, Johnson MC (2010) Robust variance estimation in meta-regression with dependent effect size estimates. Res Synth Methods 1:39-65.
25. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557-560.
26. Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K, Javors MA, Ma JZ (2003) Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 361:1677-1685.
27. Johnson BA, Rosenthal N, Capece JA, Wiegand F, Mao L, Beyers K, McKay A, Ait-Daoud N, Anton RF, Ciraulo DA, Kranzler HR, Mann K, O'Malley SS, Swift RM (2007) Topiramate for treating alcohol dependence-a randomized controlled trial. JAMA 298:1641-1651.
28. Kampman KM, Pettinati HM, Lynch KG, Spratt K, Wierzbicki MR, O'Brien CP (2013) A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence. Drug Alcohol Dep 133:94-99.
29. Kenna GA, Lomastro TL, Schiesl A, Leggio L, Swift RM (2009) Review of topiramate: an antiepileptic for the treatment of alcohol dependence. Curr Drug Abuse Rev 2:135-142.
30. Knapp G, Hartung J (2003) Improved tests for a random effects meta-regression with a single covariate. Stat Med 22:2693-2710.
31. Kranzler HR, Covault J, Feinn R, Armeli S, Tennen H, Arias AJ, Gelernter J, Pond T, Oncken C, Kampman KM (2014) Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism. Am J Psychiatry 171:445-452.
32. Likhitsathian S, Uttawichai K, Booncharoen H, Wittayanookulluk A, Angkurawaranon C, Srisurapanont M (2013) Topiramate treatment for alcoholic outpatients recently receiving residential treatment programs: a 12-week, randomized, placebo-controlled trial. Drug Alcohol Dep 133:440-446.
33. Maisel NC, Blodgett JC, Wilbourne PL, Humphreys K, Finney JW (2013) Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful? Addiction 108:275-293.
34. Olmsted CL, Kockler DR (2008) Topiramate for alcohol dependence. Ann Pharmacother 42:1475-1480.
35. Paparrigopoulos T, Tzavellas E, Karaiskos D, Kourlaba G, Liappas I (2011) Treatment of alcohol dependence with low-dose topiramate: an open-label controlled study. BMC Psychiatry 11:41-48.
36. Raudenbush S (2009) Analyzing effect sizes: random-effects models, in The Handbook of Research Synthesis and Meta-Analysis, 2nd ed (Cooper H, Hedges LV, Valentine JC eds), pp 295-315. Russell Sage Foundation, New York.
37. Rubio G, Martinez-Gras I, Manzanares J (2009) Modulation of impulsivity by topiramate implications for the treatment of alcohol dependence. J Clin Psychopharmacol 29:584-589.
38. Shadish W, Robinson L, Lu C (1999) ES: A Computer Program and Manual for Effect Size Calculation [statistical software program]. 1st ed. Assessment Systems, Minneapolis, MN.
39. Shadish WR, Haddock CK (2009) Combining estimates of effect size, in The Handbook of Research Synthesis and Meta-Analysis, 2nd ed (Cooper H, Hedges LV, Valentine JC eds), pp 257-277. Russell Sage Foundation, New York.
40. Trikalinos TA, Churchill R, Ferri M, Leucht S, Tuunainen A, Wahlbeck K, Ioannidis J (2004) Effect sizes in cumulative meta-analyses of mental health randomized trials evolved over time. J Clin Epidemiol 57:1124-1130.
41. Viechtbauer W (2005) Bias and efficiency of meta-analytic variance estimators in the random-effects model. J Educ Behav Stat 30:261-293.